Paid Clinical Trials Tacoma

Discover 932 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 932

OfatumumabPharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Tacoma WA, Salt Lake City UT, Los Angeles CA, Basalt COshow 20 more

Code:

NCT06869785

Conditions

Relapsing Multiple Sclerosis (RMS)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Ofatumumab approved dose

Ofatumumab new dose

ABBV-383A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma

Recruiting

PHASE1

Sponsor:

TeneoOne Inc.

Location:

Tacoma WA, Seattle WA, Eugene OR, Aurora COshow 19 more

Code:

NCT05650632

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-383

Adagloxad SimoleninStudy of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

Recruiting

PHASE3

Sponsor:

OBI Pharma, Inc

Location:

Tacoma WA, San Francisco CA, La Jolla CA, San Diego CAshow 9 more

Code:

NCT03562637

Conditions

Triple Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

adagloxad simolenin combined with OBI-821

Globo H IHC Assay

Standard of care treatment

MATCHMatching Adults to Treatments for Chronic Pain (MATCH) Study

Recruiting

Sponsor:

University of Washington

Location:

Tacoma WA, Seattle WA

Code:

NCT05699252

Conditions

Chronic Pain

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cognitive Behavioral Therapy (CBT)

Hypnotic Cognitive Therapy (HYP-CT)

Mindfulness-Based Cognitive Therapy (MBCT)

RavulizumabARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Tacoma WA, Seattle WA, Edmonton, San Francisco CAshow 43 more

Code:

NCT05746559

Conditions

Chronic Kidney Disease

CKD

Cardiac Disease

Cardiopulmonary Bypass

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Ravulizumab

Rilvegostomig & PembrolizumabA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Tacoma WA, Seattle WA, Olympia WA, Silverdale WAshow 53 more

Code:

NCT06692738

Conditions

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rilvegostomig

Pembrolizumab

Carboplatin

Paclitaxel

Nab-paclitaxel

NEO212Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Recruiting

PHASE1

PHASE2

Sponsor:

Neonc Technologies, Inc.

Location:

Tacoma WA, Beverly Hills CA

Code:

NCT06047379

Conditions

Diffuse Astrocytoma, IDH-Mutant

Glioblastoma, IDH-wildtype

Brain Metastases, Adult

Cervical Cancer

Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NEO212 Oral Capsule

Ipilimumab

Pembrolizumab

Nivolumab

Regorafenib

ABBV-706, Budigalimab, Cisplatin, CarboplatinStudy to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

AbbVie

Location:

Tacoma WA, Salt Lake City UT, Duarte CA, Irvine CAshow 17 more

Code:

NCT05599984

Conditions

Advanced Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-706

Cisplatin

Budigalimab

Carboplatin

LUT014LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

Recruiting

PHASE2

Sponsor:

Lutris Pharma Ltd.

Location:

Tacoma WA, Everett WA, Glendale CA, Santa Monica CAshow 11 more

Code:

NCT04759664

Conditions

EGFRI Induced Acneiform Lesions

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LUT014 Gel (Dose 1)

LUT014 Gel (Dose 2)

Placebo

Ribociclib, Alpelisib, EverolimusPhase 1b Combo w/ Ribociclib, Alpelisib, or Everolimus

Recruiting

PHASE1

Sponsor:

Olema Pharmaceuticals, Inc.

Location:

Tacoma WA, San Francisco CA, Aurora CO, Gilbert AZshow 10 more

Code:

NCT05508906

Conditions

Metastatic Breast Cancer

Advanced Breast Cancer

ER-positive Breast Cancer

HER2-negative Breast Cancer

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

OP-1250

Ribociclib

Alpelisib

Everolimus